What a GLP-1 is
GLP-1 stands for glucagon-like peptide-1 — a hormone your small intestine releases every time you eat. It's one of the body's natural "I've had enough" signals: it tells your brain you're full, tells your stomach to slow down, and tells your pancreas to manage blood sugar. The catch is that natural GLP-1 breaks down within minutes.
GLP-1 medications are engineered versions of that same hormone, redesigned to last for about a week instead of a few minutes. So rather than introducing something foreign, they amplify and extend a signal your body already uses. That's why people often describe the effect not as being forced to eat less, but as simply not thinking about food as much.
The one-line version
GLP-1 medications make a hormone your body already produces last longer — quieting hunger, slowing digestion and steadying blood sugar, all at once.
The three ways it works
The reason GLP-1 therapy feels different from willpower-based dieting is that it acts in three places at the same time. None of them is dramatic on its own; together, they quietly reshape how you experience hunger.
1. It quiets the "food noise"
GLP-1 receptors sit in the appetite centres of the brain, including the hypothalamus. By keeping those receptors gently engaged, the medication lowers the constant background hum of cravings and food-seeking thoughts that many people live with. This is the change members tend to notice first — usually within the first two to three weeks.
2. It slows your stomach down
GLP-1 slows gastric emptying — the rate at which food leaves your stomach. Food sits a little longer, so you feel satisfied sooner and stay full longer on smaller portions. It's also why the most common early side effects are digestive: nausea or feeling full quickly, especially in the first days after a dose increase.
3. It steadies your blood sugar
When you eat, GLP-1 prompts the pancreas to release insulin and suppresses glucagon, the hormone that raises blood sugar. The result is fewer of the sharp spikes and crashes that drive cravings an hour or two after a meal. This blood-sugar effect is why semaglutide was first approved to treat type 2 diabetes, before its weight effects were studied.
| The mechanism | What you feel |
|---|---|
| Appetite signalling in the brain | Less food noise, fewer cravings |
| Slower gastric emptying | Full sooner, satisfied longer |
| Insulin & glucagon balance | Steadier energy, fewer crashes |
Semaglutide vs tirzepatide
Most GLP-1 conversations involve two molecules. They work on the same principle but aren't identical.
- Semaglutide is a single-hormone GLP-1 agonist — it targets the GLP-1 receptor. It's the active ingredient in several well-known branded products and is the most studied option for weight management.
- Tirzepatide is a dual agonist: it targets the GLP-1 receptor and a second gut hormone receptor called GIP. In clinical trials this dual action has tended to produce somewhat larger average weight changes, though individual results vary widely.
Which one is appropriate — if either is — depends on your health history, how you respond and what your clinician recommends. We keep a plain-language comparison library for the specific products people ask about most.
What to realistically expect
GLP-1 therapy is a slow build, not a switch. Doses start low and increase gradually — a process called titration — to let your body adjust and to keep side effects manageable.
- Weeks 1–4: The lowest dose. Many people notice quieter cravings before they notice any change on the scale.
- Weeks 4–12: Dose steps up on a schedule your clinician sets. Appetite changes become more consistent.
- Months 3–9: The period where most sustained weight change tends to appear, alongside nutrition and movement habits.
Safety & who it's not for
Like any prescription medication, GLP-1 therapy has real risks and isn't appropriate for everyone. Common early side effects are digestive — nausea, feeling full quickly, occasional constipation or reflux — and usually ease as your body adjusts to each dose.
More serious risks are less common but important. GLP-1 medications carry warnings related to pancreatitis and gallbladder disease, and a boxed warning regarding thyroid C-cell tumours observed in animal studies. They are generally not prescribed to people with a personal or family history of medullary thyroid carcinoma or MEN 2, and aren't used during pregnancy.
This is why there's always a review
Because of these contraindications, a licensed clinician reviews your full history before anything is prescribed. It's not a formality — it's how the therapy is kept safe. Always read your patient information leaflet and raise any concerns with your care team.
The bottom line
GLP-1 medications aren't a trick or a stimulant. They extend a natural fullness hormone so that hunger gets quieter, digestion slows, and blood sugar steadies — making the everyday habits of weight care meaningfully easier to sustain. They're powerful, they're prescription-only, and they work best as one part of a supported plan.
If you're wondering whether they might be a fit, the simplest next step is to check where your BMI sits against the clinical criteria — then talk it through with a clinician.